Literature DB >> 19465834

Secondary pulmonary alveolar proteinosis: a confusing and potentially serious complication of hematologic malignancy.

Jonathan H Chung1, Sudhakar J Pipavath, David H Myerson, David Godwin.   

Abstract

OBJECTIVE: We analyzed the computed tomography and clinical findings of pulmonary alveolar proteinosis secondary to hematologic malignancy.
MATERIALS AND METHODS: Seven patients with hematologic malignancy and pathologically proven secondary pulmonary alveolar proteinosis were identified from 2000 to 2007. Six had chest computed tomography scans, which were analyzed retrospectively; medical records were also reviewed.
RESULTS: Patient age ranged from 30 to 54 years. Four had chronic myelogenous leukemia, 1 had myelodysplastic syndrome, and 1 had cutaneous T-cell lymphoma. As in idiopathic pulmonary alveolar proteinosis, geographic ground-glass opacities with or without septal thickening were most common (5/6). No axial or zonal predominance was present. Two patients died from respiratory failure.
CONCLUSIONS: It is important to consider secondary pulmonary alveolar proteinosis as a cause of geographic ground-glass opacities and septal thickening in a patient with hematologic malignancy. Whereas idiopathic pulmonary alveolar proteinosis has a low mortality rate, the death of 2 of our 6 patients implies that secondary pulmonary alveolar proteinosis may have a worse prognosis. Our case of secondary pulmonary alveolar proteinosis associated with cutaneous T-cell lymphoma is the first described in the literature.

Entities:  

Mesh:

Year:  2009        PMID: 19465834      PMCID: PMC2742334          DOI: 10.1097/RTI.0b013e3181930ed6

Source DB:  PubMed          Journal:  J Thorac Imaging        ISSN: 0883-5993            Impact factor:   3.000


  25 in total

Review 1.  Pulmonary alveolar proteinosis.

Authors:  Bruce C Trapnell; Jeffrey A Whitsett; Koh Nakata
Journal:  N Engl J Med       Date:  2003-12-25       Impact factor: 91.245

2.  Acute respiratory failure caused by secondary alveolar proteinosis in a patient with acute myeloid leukemia: a case report.

Authors:  A Gacouin; Y Le Tulzo; E Suprin; E Briens; M Bernard; C Camus; R Thomas
Journal:  Intensive Care Med       Date:  1998-03       Impact factor: 17.440

3.  Secondary pulmonary alveolar proteinosis occurring in two patients with acquired immune deficiency syndrome.

Authors:  F L Ruben; T S Talamo
Journal:  Am J Med       Date:  1986-06       Impact factor: 4.965

Review 4.  Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review.

Authors:  U B Prakash; S S Barham; H A Carpenter; D E Dines; H M Marsh
Journal:  Mayo Clin Proc       Date:  1987-06       Impact factor: 7.616

Review 5.  What every radiologist should know about idiopathic interstitial pneumonias.

Authors:  Christina Mueller-Mang; Claudia Grosse; Katharina Schmid; Leopold Stiebellehner; Alexander A Bankier
Journal:  Radiographics       Date:  2007 May-Jun       Impact factor: 5.333

6.  Pulmonary alveolar proteinosis: CT findings.

Authors:  J D Godwin; N L Müller; J E Takasugi
Journal:  Radiology       Date:  1988-12       Impact factor: 11.105

7.  Defective expression of granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 receptor common beta chain in children with acute myeloid leukemia associated with respiratory failure.

Authors:  U Dirksen; U Hattenhorst; P Schneider; H Schroten; U Göbel; A Böcking; K M Müller; R Murray; S Burdach
Journal:  Blood       Date:  1998-08-15       Impact factor: 22.113

8.  [An autopsy case of acute lymphocytic leukemia associated with secondary pulmonary alveolar proteinosis and systemic aspergillosis].

Authors:  H Kita; S Muro; Y Nakano; N Hattori; T Mizutani; H Kagioka; M Fujita
Journal:  Nihon Kyobu Shikkan Gakkai Zasshi       Date:  1993-03

9.  Secondary alveolar proteinosis is a reversible cause of respiratory failure in leukemic patients.

Authors:  C Cordonnier; J Fleury-Feith; E Escudier; K Atassi; J F Bernaudin
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

10.  Pulmonary alveolar proteinosis in a patient with acute lymphoid leukemia regression after G-CSF therapy.

Authors:  Gülsüm Emel Pamuk; Burhan Turgut; Ozden Vural; Muzaffer Demir; Osman Hatipoğlu; Ercüment Unlü; Semsi Altaner; Murat Gerenli; Bilge Cakir
Journal:  Leuk Lymphoma       Date:  2003-05
View more
  8 in total

1.  Successful whole lung lavage in a child with pulmonary alveolar proteinosis secondary to hematologic malignancy.

Authors:  Katharine Tsukahara; Robert B Lindell; Haley Newman; Benjamin J Lerman; Leslie S Kersun; Joseph Piccione
Journal:  Pediatr Pulmonol       Date:  2021-10-13

Review 2.  [Lung involvement in hematologic systemic diseases].

Authors:  S-S Stecher; S Lippl; H J Stemmler; J Schreiber
Journal:  Internist (Berl)       Date:  2018-09       Impact factor: 0.743

3.  Unsuspected pulmonary alveolar proteinosis in a patient with a slow resolving pneumonia: A case report.

Authors:  Stephanie Main; Vikas Somani; Angus Molyneux; Milan Bhattacharya; Rabinder Randhawa; Ajikumar Kavidasan
Journal:  Respir Med Case Rep       Date:  2013-06-26

4.  Clinical features of secondary pulmonary alveolar proteinosis associated with myelodysplastic syndrome: Two case reports.

Authors:  Yin Liu; Lu Lu Chen; Yu Ying Qiu; Yong Long Xiao; Hou Rong Cai
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

5.  Chronic myelomonocytic leukemia-associated pulmonary alveolar proteinosis: A case report and review of literature.

Authors:  Can Chen; Xi-Lian Huang; Da-Quan Gao; Yi-Wei Li; Shen-Xian Qian
Journal:  World J Clin Cases       Date:  2021-02-16       Impact factor: 1.337

6.  Characteristics of hospital admissions for pulmonary alveolar proteinosis: analysis of the nationwide inpatient sample (2012-2014).

Authors:  Chongiin Kim; Rodrigo Garcia-Tome; Carolina Hurtado; Li Ding; Tisha Wang; Ching-Fei Chang
Journal:  BMC Pulm Med       Date:  2022-09-24       Impact factor: 3.320

7.  ABL tyrosine kinase inhibitor-induced pulmonary alveolar proteinosis in chronic myeloid leukemia.

Authors:  Mariko Yoshimura; Kensuke Kojima; Rika Tomimasu; Noriyasu Fukushima; Shinichiro Hayashi; Eisaburo Sueoka; Shinya Kimura
Journal:  Int J Hematol       Date:  2014-09-12       Impact factor: 2.490

8.  Secondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis: a retrospective cohort study in Japan.

Authors:  Haruyuki Ishii; John F Seymour; Ryushi Tazawa; Yoshikazu Inoue; Naoyuki Uchida; Aya Nishida; Yoshihito Kogure; Takeshi Saraya; Keisuke Tomii; Toshinori Takada; Yuko Itoh; Masayuki Hojo; Toshio Ichiwata; Hajime Goto; Koh Nakata
Journal:  BMC Pulm Med       Date:  2014-03-05       Impact factor: 3.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.